Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3121)
All Articles published online
|
Oct 21, 2005 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Becker G, Soezgen T, Olschewski M, Laubenberger J, Blum HE, Allgaier HP. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterol 2005; 11(39): 6104-6109 [PMID: 16273634 DOI: 10.3748/wjg.v11.i39.6104] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i39/6104.htm |
| Number | Citing Articles |
| 1 |
H. E. Blum, L. Lan, H. C Spangenberg. Future Perspectives in Gastroenterology. 2008; : 241 doi: 10.1007/978-1-4020-8833-9_21
|
| 2 |
Hiroyuki Kirikoshi, Satoru Saito, Masato Yoneda, Koji Fujita, Hironori Mawatari, Takashi Uchiyama, Takuma Higurashi, Ayumu Goto, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Takashi Sakaguchi, Norio Ueno, Atsushi Nakajima. Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma. Hepatology Research 2009; 39(6): 553 doi: 10.1111/j.1872-034X.2009.00490.x
|
| 3 |
Maria Pleguezuelo, Giacomo Germani, Laura Marelli, Elias Xiruochakis, Maria Misseri, Pinelopi Manousou, Vasiliki Arvaniti, Andrew K Burroughs. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2008; 2(6): 761 doi: 10.1586/17474124.2.6.761
|
| 4 |
Andrew J. Page, David Cosgrove, Timothy M. Pawlik. Comparative Effectiveness in Surgical Oncology. Cancer Treatment and Research 2015; 164: 195 doi: 10.1007/978-3-319-12553-4_11
|
| 5 |
Dexiao Huang, Yong Chen, Qingle Zeng, Jianbo Zhao, Xizhong Wu, Renhua Wu, Yanhao Li. Blood supply characteristics of pedunculated hepatocellular carcinoma prior to and following transcatheter arterial chemoembolization treatment: An angiographic demonstration. Oncology Letters 2018; doi: 10.3892/ol.2018.7844
|
| 6 |
Beatrijs A. Seinstra, Otto M. van Delden, Karel J. van Erpecum, Richard van Hillegersberg, Willem P. Th. M. Mali, Maurice A. A. J. van den Bosch. Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?. Insights into Imaging 2010; 1(3): 167 doi: 10.1007/s13244-010-0027-6
|
| 7 |
Tian Tian, Ju Guo, Ju-Lan Hu, Yue Hu, Ping Guo, Xiao-Yun Yu. Advanced hepatocellular carcinoma and palliative care: a scoping review. BMJ Supportive & Palliative Care 2022; : bmjspcare-2022-003798 doi: 10.1136/spcare-2022-003798
|
| 8 |
K. T. Tan, C. S. Ho. Interventional Radiological Treatment of Liver Tumors. 2008; : 108 doi: 10.1017/CBO9780511575433.008
|
| 9 |
Zachary J. Brown, D Brock Hewitt, Timothy M Pawlik. Combination therapies plus transarterial chemoembolization in hepatocellular carcinoma: a snapshot of clinical trial progress. Expert Opinion on Investigational Drugs 2022; 31(4): 379 doi: 10.1080/13543784.2022.2008355
|
| 10 |
Michael A. Heneghan, Andrew D. Yeoman. Malignant Liver Tumors. 2010; : 266 doi: 10.1002/9781444317053.ch22
|
| 11 |
Hui Xie, Haipeng Yu, Shengtao Tian, Xueling Yang, Ximing Wang, Zhao Yang, Huaming Wang, Zhi Guo. What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis. Oncotarget 2017; 8(59): 100508 doi: 10.18632/oncotarget.20119
|
| 12 |
Davide Roccarina, Avik Majumdar, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Management of people with intermediate-stage hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD011649.pub2
|
| 13 |
Ran Tao, Xiaodan Li, Ruizhi Ran, Zhihua Xiao, Hongyue Zhang, Hongyan Kong, Qiqin Song, Yu Huang, Likui Wang, Jiaquan Huang. A mixed analysis comparing nine minimally invasive surgeries for unresectable hepatocellular carcinoma patients. Oncotarget 2017; 8(3): 5460 doi: 10.18632/oncotarget.12348
|
| 14 |
Marc Giovannini. Le traitement percutané du carcinome hépato-cellulaire. Gastroentérologie Clinique et Biologique 2007; 31(3): 347 doi: 10.1016/S0399-8320(07)89388-2
|
| 15 |
S. Kubicka, M.P. Manns. Hepatozelluläres Karzinom. Der Gastroenterologe 2008; 3(2): 147 doi: 10.1007/s11377-008-0166-1
|
| 16 |
Masashi Mizumoto, Koichi Tokuuye, Shinji Sugahara, Hidetsugu Nakayama, Nobuyoshi Fukumitsu, Kiyoshi Ohara, Masato Abei, Junichi Shoda, Eriko Tohno, Manabu Minami. Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Porta Hepatis. International Journal of Radiation Oncology*Biology*Physics 2008; 71(2): 462 doi: 10.1016/j.ijrobp.2007.09.056
|
| 17 |
Judith Meza-Junco, Aldo J. Montano-Loza, David M. Liu, Michael B. Sawyer, Vincent G. Bain, Mang Ma, Richard Owen. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?. Cancer Treatment Reviews 2012; 38(1): 54 doi: 10.1016/j.ctrv.2011.05.002
|
| 18 |
Chuang Jiang, Gong Cheng, Mingheng Liao, Jiwei Huang. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02188-4
|
| 19 |
S. Kubicka, M. P. Manns. Leberzellkarzinom. best practice onkologie 2008; 3(5): 6 doi: 10.1007/s11654-008-0077-0
|
| 20 |
Josep M. Llovet, Thierry De Baere, Laura Kulik, Philipp K. Haber, Tim F. Greten, Tim Meyer, Riccardo Lencioni. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2021; 18(5): 293 doi: 10.1038/s41575-020-00395-0
|
| 21 |
Shiying Wang, Liping Zhuang, Zhiqiang Meng. Hepatocellular Carcinoma More Than 3 cm in Diameter: A Systematic Review of Transcatheter Arterial Chemoembolization Plus Percutaneous Ethanol Injection versus Transcatheter Arterial Chemoembolization Alone. ISRN Gastroenterology 2013; 2013: 1 doi: 10.1155/2013/526024
|
| 22 |
J Kim, D J Chung, S E Jung, S H Cho, S-T Hahn, J M Lee. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy—preliminary observations. The British Journal of Radiology 2012; 85(1018): e940 doi: 10.1259/bjr/32750755
|
| 23 |
Emmanuel A. Tsochatzis, Evangelia M. Fatourou, Christos K. Triantos, Andrew K. Burroughs. Multidisciplinary Treatment of Hepatocellular Carcinoma. Recent Results in Cancer Research 2013; 190: 195 doi: 10.1007/978-3-642-16037-0_13
|
| 24 |
Na Wang, Quanlin Guan, Kai Wang, Bingdong Zhu, Wenzhen Yuan, Peng Zhao, Xiaowei Wang, Yongxun Zhao. TACE combined with PEI versus TACE alone in the treatment of HCC: a meta-analysis. Medical Oncology 2011; 28(4): 1038 doi: 10.1007/s12032-010-9620-2
|
| 25 |
Emmanuel A. Tsochatzis, Giacomo Germani, Andrew K. Burroughs. Transarterial Chemoembolization, Transarterial Chemotherapy, and Intra-arterial Chemotherapy for Hepatocellular Carcinoma Treatment. Seminars in Oncology 2010; 37(2): 89 doi: 10.1053/j.seminoncol.2010.03.007
|
| 26 |
Lili Gu, Huiling Liu, Linlin Fan, Yuanjun Lv, Zhuang Cui, Yan Luo, Yuanyuan Liu, Guang Li, Changping Li, Jun Ma. Treatment outcomes of transcatheter arterial chemoembolization combined with local ablative therapy versus monotherapy in hepatocellular carcinoma: a meta-analysis. Journal of Cancer Research and Clinical Oncology 2014; 140(2): 199 doi: 10.1007/s00432-013-1528-8
|
| 27 |
Jingxin Yan, Manjun Deng, Ting Li, Changhao Dong, Minglan Wang, Shunyu Kong, Yingxing Guo, Haining Fan. Efficacy and complications of transarterial chemoembolization alone or in combination with different protocols for hepatocellular carcinoma: A Bayesian network meta-analysis of randomized controlled trials. iLIVER 2023; 2(2): 130 doi: 10.1016/j.iliver.2023.03.002
|
| 28 |
Baoxian Liu, Chunlin Jiang, Shuling Chen, Guangliang Huang, Yu Wang, Jiaping Li, Ming Xu, Xiaoyan Xie, Ming Kuang. Multipronged ethanol ablation combined with TACE for intermediate hepatocellular carcinoma. Minimally Invasive Therapy & Allied Technologies 2018; 27(5): 300 doi: 10.1080/13645706.2018.1427598
|
| 29 |
Lei Li, Jiangke Tian, Peng Liu, Xuan Wang, Zhenyu Zhu. Transarterial Chemoembolization Combination Therapy vs Monotherapy in Unresectable Hepatocellular Carcinoma: A Meta-Analysis. Tumori Journal 2016; 102(3): 301 doi: 10.5301/tj.5000491
|
| 30 |
Masatoshi Tanaka, Eiji Ando, Shigeo Simose, Maisa Hori, Kei Kuraoka, Miki Ohno, Shigeru Yutani, Kazunori Harada, Michio Sata. Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma. Hepatology Research 2014; 44(2): 194 doi: 10.1111/hepr.12100
|
| 31 |
H.C. Spangenberg, L. Mohr, H.E. Blum. Regionale Therapie von Lebertumoren. Der Internist 2007; 48(1): 40 doi: 10.1007/s00108-006-1771-z
|
| 32 |
P. M. LOPEZ, A. VILLANUEVA, J. M. LLOVET. Systematic review: evidence‐based management of hepatocellular carcinoma – an updated analysis of randomized controlled trials. Alimentary Pharmacology & Therapeutics 2006; 23(11): 1535 doi: 10.1111/j.1365-2036.2006.02932.x
|
| 33 |
Chapter 6: Local ablation therapy. Hepatology Research 2010; 40(s1): 113 doi: 10.1111/j.1872-034X.2010.00659.x
|
| 34 |
Konstantinos Katsanos, Panagiotis Kitrou, Stavros Spiliopoulos, Ioannis Maroulis, Theodore Petsas, Dimitris Karnabatidis, Sheng-Nan Lu. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials. PLOS ONE 2017; 12(9): e0184597 doi: 10.1371/journal.pone.0184597
|
| 35 |
Mingheng Liao, Jiwei Huang, Tao Zhang, Hong Wu, William B. Coleman. Transarterial Chemoembolization in Combination with Local Therapies for Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE 2013; 8(7): e68453 doi: 10.1371/journal.pone.0068453
|
| 36 |
Wei Wang, Jian Shi, Wei-Fen Xie. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver International 2010; 30(5): 741 doi: 10.1111/j.1478-3231.2010.02221.x
|
| 37 |
Dexiao Huang, Yong Chen, Shuo Chen, Qingle Zeng, Jianbo Zhao, Renhua Wu, Yanhao Li. TACE plus percutaneous chemotherapy-lipiodol treatment of unresectable pedunculated hepatocellular carcinoma. Medicine 2017; 96(30): e7650 doi: 10.1097/MD.0000000000007650
|
| 38 |
Srikanth Padma, John B. Martinie, David A. Iannitti. Liver tumor ablation: Percutaneous and open approaches. Journal of Surgical Oncology 2009; 100(8): 619 doi: 10.1002/jso.21364
|
| 39 |
Luca Tagliaferri, Andrea D’Aviero, Alessandro Posa, Roberto Iezzi. Manual on Image-Guided Brachytherapy of Inner Organs. 2021; : 201 doi: 10.1007/978-3-030-78079-1_16
|
| 40 |
Practice guidelines for management of hepatocellular carcinoma 2009. The Korean Journal of Hepatology 2009; 15(3): 391 doi: 10.3350/kjhep.2009.15.3.391
|
| 41 |
|
| 42 |
Harsh A. Kanhere, Lisa N. Leopardi, Louise Fischer, Michael I. Kitchener, Guy J. Maddern. TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA WITH RADIOLABELLED LIPIODOL. ANZ Journal of Surgery 2008; 78(5): 371 doi: 10.1111/j.1445-2197.2008.04480.x
|
| 43 |
Shelley R. Salpeter, Dawn S. Malter, Esther J. Luo, Albert Y. Lin, Brad Stuart. Systematic Review of Cancer Presentations with a Median Survival of Six Months or Less. Journal of Palliative Medicine 2012; 15(2): 175 doi: 10.1089/jpm.2011.0192
|
| 44 |
Bo Sun, Weihua Zhang, Lei Chen, Tao Sun, Yanqiao Ren, Licheng Zhu, Kun Qian, Chuansheng Zheng. The safety and efficacy of percutaneous ethanol injection in the treatment of tumor thrombus in advanced hepatocellular carcinoma with portal vein tumor thrombus. Abdominal Radiology 2022; 47(2): 858 doi: 10.1007/s00261-021-03349-5
|
| 45 |
H.C. Spangenberg, O. Drognitz, R. Thimme, U. Hopt. Das hepatozelluläre Karzinom aus der Sicht des Internisten und des Chirurgen. Der Gastroenterologe 2009; 4(4): 301 doi: 10.1007/s11377-009-0305-3
|
| 46 |
Riccardo Inchingolo, Alessandro Posa, Martin Mariappan, Stavros Spiliopoulos. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions. World Journal of Gastroenterology 2019; 25(32): 4614-4628 doi: 10.3748/wjg.v25.i32.4614
|
| 47 |
Sudhanshu Gogia, Alex S. Befeler. Treating hepatocellular carcinoma without liver transplantation. Current Gastroenterology Reports 2009; 11(1): 69 doi: 10.1007/s11894-009-0011-9
|
| 48 |
Jianghai Zhao, Hui Zhang, Lunshou Wei, Shuping Xie, Zhimin Suo. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison. Oncotarget 2017; 8(9): 15101 doi: 10.18632/oncotarget.13145
|
| 49 |
Joon-Il Choi, Hyun Beom Kim, Min Ju Kim, Jong Seok Lee, Young Whan Koh, Sang Bu An, Heung-kyu Ko, Joong-Won Park. Noncontrast chest computed tomography immediately after transarterial chemoembolization in patients with hepatocellular carcinoma: Clinical benefits and effect of radiation reduction on image quality in low-dose scanning. European Journal of Radiology 2011; 80(2): e188 doi: 10.1016/j.ejrad.2011.06.009
|
| 50 |
Yasuharu Imai. Combination of transarterial chemoembolization and percutaneous local ablation therapy for hepatocellular carcinoma. Hepatology Research 2010; 40(1): 105 doi: 10.1111/j.1872-034X.2009.00610.x
|
| 51 |
Andrew Hines-Peralta, S. Nahum Goldberg. Interventional Oncology. 2008; : 55 doi: 10.1017/CBO9780511722226.006
|
| 52 |
Laura M. Kulik, Mary F. Mulcahy, Reed A. Omary, Riad Salem. Emerging Approaches in Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 2007; 41(9): 839 doi: 10.1097/MCG.0b013e318060ac52
|
| 53 |
Giuseppe Cabibbo, Federica Latteri, Michela Antonucci, Antonio Craxì. Multimodal approaches to the treatment of hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2009; 6(3): 159 doi: 10.1038/ncpgasthep1357
|
| 54 |
Luigi Bolondi, Umberto Cillo, Massimo Colombo, Antonio Craxì, Fabio Farinati, Edoardo G. Giannini, Rita Golfieri, Massimo Levrero, Antonio Daniele Pinna, Fabio Piscaglia, Giovanni Raimondo, Franco Trevisani, Raffaele Bruno, Paolo Caraceni, Alessia Ciancio, Barbara Coco, Mirella Fraquelli, Maria Rendina, Giovanni Squadrito, Pierluigi Toniutto. Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma. Digestive and Liver Disease 2013; 45(9): 712 doi: 10.1016/j.dld.2013.01.012
|
| 55 |
H. C. Spangenberg. Lokal-ablative Therapie. Der Gastroenterologe 2007; 2(1): 27 doi: 10.1007/s11377-006-0057-2
|
| 56 |
Eun Kyung Paik, Mi-Sook Kim, Won Il Jang, Young Seok Seo, Chul-Koo Cho, Hyung Jun Yoo, Chul Ju Han, Su Cheol Park, Sang Bum Kim, Young Han Kim. Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma. Radiation Oncology 2016; 11(1) doi: 10.1186/s13014-016-0597-7
|
| 57 |
Laura Marelli, Rosa Stigliano, Christos Triantos, Marco Senzolo, Evangelos Cholongitas, Neil Davies, Dominic Yu, Tim Meyer, David W. Patch, A.K. Burroughs. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treatment Reviews 2006; 32(8): 594 doi: 10.1016/j.ctrv.2006.08.002
|
| 58 |
Giovan Giuseppe Di Costanzo, Raffaella Tortora. Intermediate hepatocellular carcinoma: How to choose the best treatment modality?. World Journal of Hepatology 2015; 7(9): 1184-1191 doi: 10.4254/wjh.v7.i9.1184
|
| 59 |
Ik Yoon, Hyung Joon Yim, Jin Nam Kim, Sun Min Park, Jeong Han Kim, Seung Hwa Lee, Hwan Hoon Chung, Hong Sik Lee, Sang Woo Lee, Jai Hyun Choi. A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy. The Korean Journal of Hepatology 2009; 15(1): 90 doi: 10.3350/kjhep.2009.15.1.90
|
| 60 |
Do Seon Song, Soon Woo Nam, Si Hyun Bae, Jin Dong Kim, Jeong Won Jang, Myeong Jun Song, Sung Won Lee, Hee Yeon Kim, Young Joon Lee, Ho Jong Chun, Young Kyoung You, Jong Young Choi, Seung Kew Yoon. Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(8): 2395-2404 doi: 10.3748/wjg.v21.i8.2395
|